Failure to Modify Scrapie in Mice by Administration of Interferon or Anti-interferon Globulin

References

1. Chandler R. L. 1961; Encephalopathy in mice produced with scrapie brain material. Lancet 1:1378–1379
   [Google Scholar]
2. Fauconnier B. 1970; Augmentation de la pathogenicite virale pa′r l’emploi de serum anti-interferon in vivo. Comptes rendus hebdomadaires des seances de I’Academie des sciences 271:1464–1466
   [Google Scholar]
3. Field E. J., Joyce G., Keith A. 1969; Failure of interferon to modify scrapie in the mouse. Journal of General Virology 5:149–150
   [Google Scholar]
4. Gresser I., Pattison I. H. 1968; An attempt to modify scrapie in mice by the administration of interferon. Journal of General Virology 3:295–297
   [Google Scholar]
5. Gresser I., Tovey M. G., Bandu M.-T., Maury C., Brouty-boye D. 1976a; Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. Journal of Experimental Medicine 144:1305–1315
   [Google Scholar]
6. Gresser I., Tovey M. G., Maury C., Bandu M. T. 1976b; Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. Journal of Experimental Medicine 144:1316–1323
   [Google Scholar]
7. Haller O., Arnheiter H., Gresser I., Lindenmann J. 1979; Genetically determined, interferon-dependent resistance to influenza virus in mice. Journal of Experimental Medicine 149:601–612
   [Google Scholar]
8. Inglot A. D., Oleszak E. 1978; Application of antisera to interferon in studying oncogenic viruses. Archivum Immunologiae et therapiae Experimentalis 26:529–536
   [Google Scholar]
9. Katz M., Koprowski H. 1968; Failure to demonstrate a relationship between scrapie and production of interferon in mice. Nature, London 219:639–640
   [Google Scholar]
10. Kimberlin R. H. 1982; Reflections on the nature of scrapie agent. Trends in Biochemical Sciences 7:392–394
    [Google Scholar]
11. Kimberlin R. H., Walker C. A. 1979; Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. Journal of Comparative Pathology 89:551–561
    [Google Scholar]
12. Prusiner S. B. 1982; Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
    [Google Scholar]
13. Stewart W. E. II 1979 In The Interferon System pp 266–290 Wien & New York: Springer-Verlag;
    [Google Scholar]
14. Tovey M. G., Begon-lours J., Gresser I. 1974; A method for the large scale production of potent interferon preparations. Proceedings of the Society for Experimental Biology and Medicine 146:809–815
    [Google Scholar]
15. Virelizier J.-L., Gresser I. 1978; Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. Journal of Immunology 120:1616–1619
    [Google Scholar]